Consonance Capital Partners

What Consonance Capital Partners does

Consonance Capital is a healthcare-focused investment platform established in 2005 and headquartered at 545 Madison Avenue, 7th Floor, New York. The platform operates through two entities: Consonance Capital Partners, a private equity manager executing growth equity investments, leveraged buyouts, and recapitalizations in U.S. healthcare companies; and Consonance Capital Management, a hedge fund that previously invested in public life sciences but is no longer accepting new investor capital and now oversees only residual administrative matters. The firm is led by founder and CEO Mitchell Blutt, MD, alongside co-founders Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle on the PE side, with Kevin Livingston and Benny Soffer, MD as co-founders of the wound-down hedge fund arm.

The firm's operational footprint is a lean team of 11-50 employees based at its single New York headquarters. Its investment product surface is its sector thesis — originating, executing, and managing equity investments across U.S. healthcare sub-sectors. The disclosed acquisition track record spans healthcare services (Psychiatric Medical Care, Kepro, Orsini Healthcare), diagnostics (Bako Diagnostics), and pharma services (Enclara Pharmacia), demonstrating breadth within the healthcare vertical. The technology stack is conventional PE infrastructure; no proprietary technology platform or AI components are described in the available data.

Consonance Capital generates revenue through traditional private equity economics: management fees on committed capital and carried interest on fund returns. Its customer base consists of limited partners committing to its healthcare-focused funds and the healthcare founders and management teams receiving capital and operational support. The firm does not publicly disclose pricing, AUM, fund vintages, or revenue figures. Its narrow vertical focus — exclusively U.S. healthcare — combined with a leadership team drawn from top healthcare investment firms (GTCR, Carlyle, J.P. Morgan) constitutes its principal differentiation, though the firm operates at a smaller scale than mega-fund healthcare peers.

Name

Consonance Capital Partners

Legal name

Consonance Capital

Website

https://consonancecapital.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Consonance Capital is a New York-based healthcare investment platform founded in 2005 that operates a private equity arm executing growth equity, leveraged buyouts, and recapitalizations in U.S. healthcare companies, generating revenue from fund management fees and carried interest.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity

NAICS

Portfolio Management and Investment Advice (523940), Investment Banking and Securities Intermediation (523150)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)

akta.pro primary industry

Corporate Finance & Capital Advisory (BPAHADAB)

akta.pro secondary industries

Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG), Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC)

Keywords

• Healthcare private equity
• Growth equity investments
• Leveraged buyouts
• Healthcare recapitalizations
• Healthcare investment platform

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Private Equity Management: Consonance Capital Partners generates revenue through private equity fund management, including management fees and carried interest from investments in healthcare growth equity, leveraged buyouts, and recapitalizations.

Core offering

Consonance Capital Partners is a private equity manager that invests across the U.S. healthcare industry through growth equity, leveraged buyouts, and recapitalizations. The platform also operates Consonance Capital Management, a hedge fund that historically invested in public life sciences, though that arm is no longer making new equity investments or accepting investor capital. Founded in 2005, the firm is headquartered in New York and co-leads transactions alongside healthcare founders and management teams.

Product overview

Consonance Capital operates as a unified healthcare investment platform with two distinct product lines: Consonance Capital Partners (private equity) handles growth equity, leveraged buyouts, and recapitalizations in the U.S. healthcare sector, while Consonance Capital Management (hedge fund) previously managed public life sciences investments. The platform was created in 2005 and is led by CEO Mitchell Blutt, MD, with offices at 545 Madison Avenue, 7th Floor, New York, NY 10022.

Differentiator

Problem solved

Functional benefit

Products and services

• Consonance Capital Partners (Private Equity)

Segments1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves6 records

Expansion highlights3 records

Direct peers

• GTCR: Chicago-based growth-oriented PE firm with a longstanding Healthcare group. Notable because Consonance's new VP Charlie Kolisek previously worked at GTCR's Healthcare group, and the firm is a direct comparable in healthcare buyout activity.
• New Mountain Capital: U.S. private equity firm with a dedicated healthcare franchise investing in healthcare services, pharma services, and information. Comparable in healthcare thematic focus and growth-oriented buyout strategy.
• OrbiMed Advisors: Healthcare-dedicated investment firm across PE, growth equity, and royalties, with a focus on biopharma, medical devices, and healthcare services. Comparable healthcare-only thesis and platform-building orientation.
• Linden Capital Partners: Healthcare-dedicated middle-market PE firm investing in healthcare services, pharma services, and medical products. Direct comparable in vertical focus and platform-building approach to Consonance Capital Partners.
• Welsh, Carson, Anderson & Stowe: One of the longest-tenured U.S. healthcare-focused PE firms, investing across healthcare services, information, and life sciences. Highly comparable sector specialization, though typically larger fund vintages than Consonance.
• Avista Capital Partners: Healthcare-focused middle-market private equity firm sponsoring growth equity and buyouts in U.S. healthcare services, pharma services, and medical products — closely comparable to Consonance Capital Partners in sector, stage, and ticket size.

Emerging players

• Health Enterprise Partners: Healthcare-focused growth equity firm investing in lower-middle-market healthcare services and information technology companies. Smaller and earlier-stage than Consonance but comparable in vertical specialization.

Broad incumbents

• KKR — Healthcare Strategic Growth: Global alternative asset manager with a healthcare growth and buyout franchise. Comparable in healthcare deal activity but part of a much larger diversified PE platform.
• TPG Capital — Healthcare Team: Large diversified alternative asset manager with a dedicated healthcare practice investing across services, biopharma, and digital health. Overlapping in healthcare PE activity but operating as part of a broader multi-strategy platform.
• Bain Capital — Healthcare: Diversified alternative asset manager with a dedicated healthcare vertical spanning services, life sciences, and pharma. Overlaps with Consonance on healthcare buyout deals but at larger scale and broader strategy mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Consonance Capital Partners